Is monotherapy for febrile neutropenia still a viable alternative?
Ramphal R;;
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1999Vol. 29pp. -
352
r1999clinicalis
Abstract
Monotherapy for empirical treatment of febrile neutropenia is effective and often less costly than combination therapy but remains controversial. The controversy results from observations that combination therapy for Pseudomonas aeruginosa improved outcomes, and this approach became a standard. Many …